Claremont Bio Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $2M

  • Investors
  • 8

Claremont Bio General Information

Description

Developer of novel instrumentation and consumables designed for applications and long-read sequencing methods. The company's consumables are used for molecular diagnostics and bio-science research, such as the lysis of cells, the extraction and purification of a pathogen or genomic deoxyribonucleic acid and ribonucleic acid, and real-time detection of amplified deoxyribonucleic acid sequences, enabling the healthcare industry to handle sample matrices and pathogens.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1182 Monte Vista Avenue
  • Suite 11
  • Upland, CA 91786
  • United States
+1 (909)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 1182 Monte Vista Avenue
  • Suite 11
  • Upland, CA 91786
  • United States
+1 (909)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Claremont Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Grant 07-Apr-2021 $2M Completed Generating Revenue
11. Later Stage VC 31-Jul-2020 Completed Generating Revenue
10. Grant 02-Apr-2020 Completed Generating Revenue
9. Grant 03-Apr-2019 Completed Generating Revenue
8. Grant 15-Sep-2018 Completed Generating Revenue
7. Grant 31-Jul-2018 Completed Generating Revenue
6. Grant 31-Mar-2018 Completed Generating Revenue
5. Later Stage VC 20-Sep-2016 Completed Generating Revenue
4. Grant 30-Jun-2016 $3.6M $1.3M Completed Generating Revenue
3. Later Stage VC 13-Jul-2015 $1.3M Completed Generating Revenue
To view Claremont Bio’s complete valuation and funding history, request access »

Claremont Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel instrumentation and consumables designed for applications and long-read sequencing methods. The compa
Diagnostic Equipment
Upland, CA
12 As of 2025

Chicago, IL
 

Santa Maria, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Claremont Bio Competitors (5)

One of Claremont Bio’s 5 competitors is Maroon Biotech, a Corporation company based in Chicago, IL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Maroon Biotech Corporation Chicago, IL
Hardy Diagnostics Private Debt Financed Santa Maria, CA
Promega Formerly PE-Backed Madison, WI
Qiagen Formerly VC-backed Hilden, Germany
Etaluma Corporation Carlsbad, CA
You’re viewing 5 of 5 competitors. Get the full list »

Claremont Bio Patents

Claremont Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11479747-B2 Arrayed lyser and homogenizer systems with multiple agitator devices Active 03-Feb-2017
US-20200010789-A1 Arrayed lyser and homogenizer systems with multiple agitator devices Active 03-Feb-2017
WO-2018144723-A1 Arrayed lyser and homogenizer systems with multiple agitator devices Inactive 03-Feb-2017
US-D829339-S1 Homogenizer rack Active 08-Nov-2016
US-10801001-B2 Compositions and methods for disaggregation of biological tissue samples Active 13-Apr-2015 C12M45/02
To view Claremont Bio’s complete patent history, request access »

Claremont Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Claremont Bio Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
National Cancer Institute Government
National Institute of General Medical Sciences Government
Diligent Health Solutions Corporation
National Aeronautics and Space Administration Government
US National Science Foundation Accelerator/Incubator
You’re viewing 5 of 8 investors. Get the full list »

Claremont Bio FAQs

  • When was Claremont Bio founded?

    Claremont Bio was founded in 2006.

  • Where is Claremont Bio headquartered?

    Claremont Bio is headquartered in Upland, CA.

  • What is the size of Claremont Bio?

    Claremont Bio has 12 total employees.

  • What industry is Claremont Bio in?

    Claremont Bio’s primary industry is Diagnostic Equipment.

  • Is Claremont Bio a private or public company?

    Claremont Bio is a Private company.

  • What is Claremont Bio’s current revenue?

    The current revenue for Claremont Bio is .

  • How much funding has Claremont Bio raised over time?

    Claremont Bio has raised $2.3M.

  • Who are Claremont Bio’s investors?

    National Cancer Institute, National Institute of General Medical Sciences, Diligent Health Solutions, National Aeronautics and Space Administration, and US National Science Foundation are 5 of 8 investors who have invested in Claremont Bio.

  • Who are Claremont Bio’s competitors?

    Maroon Biotech, Hardy Diagnostics, Promega, Qiagen, and Etaluma are competitors of Claremont Bio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process